Robert J. Dempsey
Chief Executive Officer chez AsclepiX Therapeutics LLC
Profil
Robert J.
Dempsey is currently the President, Chief Executive Officer & Director at AsclepiX Therapeutics LLC, Director at International Council of Ophthalmology Foundation, and Director at iVeena Delivery Systems, Inc. He was previously the Chief Executive Officer at TearClear Corp., Director at Ocuterra Therapeutics, Inc., President at BIKAM Pharmaceuticals, Inc., and Head-Ophthalmics Business at Shire Plc.
Dempsey holds an undergraduate degree and an MBA from Northeastern University.
Postes actifs de Robert J. Dempsey
| Sociétés | Poste | Début |
|---|---|---|
iVeena Delivery Systems, Inc.
 iVeena Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology iVeena Delivery Systems, Inc. engages in the manufacture of eye drops. It develops ocular drug products that eliminate the need to apply eye drops and painful injections. The company was founded by Balamurali Ambati and is headquartered in Salt Lake, UT. | Director/Board Member | 22/10/2019 |
| International Council of Ophthalmology Foundation | Director/Board Member | - |
AsclepiX Therapeutics LLC
 AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | Chief Executive Officer | 17/03/2021 |
Anciens postes connus de Robert J. Dempsey
| Sociétés | Poste | Fin |
|---|---|---|
Ocuterra Therapeutics, Inc.
 Ocuterra Therapeutics, Inc. Drugstore ChainsRetail Trade Ocuterra Therapeutics, Inc. manufactures drug products. The company is headquartered in Boston, MA. | Director/Board Member | 14/12/2021 |
TearClear Corp.
 TearClear Corp. Medical SpecialtiesHealth Technology TearClear Corp. operates as an early-stage medical science company. It develops a hydrogel filter to remove potentially harmful preservatives from multi dose topical ophthalmic products used to treat chronic diseases such as glaucoma, dry-eye and allergic conjunctivitis. The company was founded by Anuj Chauhan in 2015 and is headquartered in Copley, OH. | Chief Executive Officer | 16/03/2021 |
BIKAM Pharmaceuticals, Inc.
 BIKAM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BIKAM Pharmaceuticals, Inc. develops ophthalmic pharmaceuticals products. It focuses on the discovery and development of novel drugs for degenerative diseases of the eye. The company was founded on June 12, 2007 by Shalesh Kaushal and is headquartered in Lexington, MA. | President | - |
| SHIRE | Corporate Officer/Principal | - |
Formation de Robert J. Dempsey
| Northeastern University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
BIKAM Pharmaceuticals, Inc.
BIKAM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology BIKAM Pharmaceuticals, Inc. develops ophthalmic pharmaceuticals products. It focuses on the discovery and development of novel drugs for degenerative diseases of the eye. The company was founded on June 12, 2007 by Shalesh Kaushal and is headquartered in Lexington, MA. | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| International Council of Ophthalmology Foundation | |
Ocuterra Therapeutics, Inc.
Ocuterra Therapeutics, Inc. Drugstore ChainsRetail Trade Ocuterra Therapeutics, Inc. manufactures drug products. The company is headquartered in Boston, MA. | Retail Trade |
iVeena Delivery Systems, Inc.
iVeena Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology iVeena Delivery Systems, Inc. engages in the manufacture of eye drops. It develops ocular drug products that eliminate the need to apply eye drops and painful injections. The company was founded by Balamurali Ambati and is headquartered in Salt Lake, UT. | Health Technology |
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD. | Commercial Services |
TearClear Corp.
TearClear Corp. Medical SpecialtiesHealth Technology TearClear Corp. operates as an early-stage medical science company. It develops a hydrogel filter to remove potentially harmful preservatives from multi dose topical ophthalmic products used to treat chronic diseases such as glaucoma, dry-eye and allergic conjunctivitis. The company was founded by Anuj Chauhan in 2015 and is headquartered in Copley, OH. | Health Technology |
